| 摘要 |
<P>PROBLEM TO BE SOLVED: To provide a dual-specific ligand having designated binding specificity. <P>SOLUTION: The dual-specific ligand includes: a first immunoglobulin variable domain having the first binding specificity; and an immunoglobulin variable domain, which is complementary or non-complementary to the first immunoglobulin variable domain, and having a second binding specificity. <P>COPYRIGHT: (C)2011,JPO&INPIT |
